Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Cash Flow Reinvestment Rate
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Cash Flow Reinvestment Rate of 7.80x as of December 2024, reinvesting CN¥187.51 Million (capex CN¥187.14 Million plus investments CN¥369.80K) from operating cash flow of CN¥24.04 Million. Explore how much does Hunan Dajiaweikang Pharmaceutical Indust reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 3 annual periods. Also explore Hunan Dajiaweikang Pharmaceutical Indust asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Year-by-year capital reinvestment analysis for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. For live market cap and broader valuation context, see how much is Hunan Dajiaweikang Pharmaceutical Indust worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.80x | CN¥187.51 Million | CN¥24.04 Million | CN¥187.14 Million | ▼ -9.7% |
| 2023 | 8.64x | CN¥234.43 Million | CN¥27.13 Million | CN¥226.70 Million | ▲ +1706.6% |
| 2019 | 0.48x | CN¥65.01 Million | CN¥135.91 Million | CN¥32.50 Million | — |